Galiñanes M, Argano V, Hearse D J
Department of Cardiovascular Research, Rayne Institute, St Thomas' Hospital, London, UK.
Circulation. 1995 Nov 1;92(9 Suppl):II389-94. doi: 10.1161/01.cir.92.9.389.
Ischemic preconditioning is a potent protective intervention that is effective in all species studied. We have previously shown it to be as effective as cardioplegia; however, we have also shown that their combined use does not afford greater protection than the use of either alone. In the present study we investigated whether coincident ischemic preconditioning could compensate for inadequate cardioplegic protection when the delivery of cardioplegia was impaired, such as occurs in the presence of severe coronary stenosis or occlusion.
Isolated rat hearts were subjected to 30 minutes of global ischemia followed by 40 minutes of reperfusion. Four groups of hearts (n = 12 per group) were studied: group 1, controls (no intervention); group 2, cardioplegia administered to hearts with a proximally occluded coronary artery; group 3, ischemic preconditioning applied before ischemia; and group 4, ischemic preconditioning and cardioplegia given in combination to hearts with a proximally occluded coronary artery. The postischemic recovery of left ventricular (LV) developed pressure (LVDP), expressed as a percentage of preischemic values, was significantly greater (P < .05) in preconditioned hearts (64 +/- 3%) than in control hearts (24 +/- 4%) or hearts treated with suboptimal cardioplegia (43 +/- 5%). Hearts with preconditioning plus cardioplegia recovered to an extent similar to that seen with preconditioning alone (59 +/- 2%). LV end-diastolic pressure was greater in control hearts (58 +/- 4 mm Hg) than in hearts with cardioplegia (41 +/- 4 mm Hg; P < .05 versus group 1) despite the incomplete delivery of the cardioplegia; the best protection was observed in preconditioned hearts and hearts with preconditioning plus cardioplegia (24 +/- 1 and 26 +/- 2 mm Hg, respectively; P < .05 versus groups 1 and 2).
When the delivery of cardioplegia was impaired, myocardial protection (postischemic LVDP) was better served by ischemic preconditioning. Under the same conditions, the combination of cardioplegia plus preconditioning afforded superior protection compared with cardioplegia alone. These results may be of clinical interest since most patients who undergo surgery for ischemic heart disease suffer from severe coronary artery lesions that can prevent the adequate delivery of cardioplegia.
缺血预处理是一种有效的保护性干预措施,在所有研究的物种中均有效。我们之前已证明它与心脏停搏液效果相当;然而,我们也表明,联合使用它们并不比单独使用其中任何一种提供更大的保护。在本研究中,我们调查了在心脏停搏液输送受损时,如在严重冠状动脉狭窄或闭塞的情况下,同时进行缺血预处理是否能弥补心脏停搏液保护不足的问题。
将离体大鼠心脏进行30分钟的全心缺血,随后再灌注40分钟。研究了四组心脏(每组n = 12):第1组,对照组(未干预);第2组,向冠状动脉近端闭塞的心脏给予心脏停搏液;第3组,在缺血前进行缺血预处理;第4组,向冠状动脉近端闭塞的心脏联合给予缺血预处理和心脏停搏液。以缺血前值的百分比表示的左心室(LV)舒张末压(LVDP)的缺血后恢复情况,预处理组心脏(64±3%)显著高于对照组心脏(24±4%)或接受次优心脏停搏液治疗的心脏(43±5%)(P <.05)。预处理加心脏停搏液的心脏恢复程度与单独预处理相似(59±2%)。尽管心脏停搏液输送不完全,但对照组心脏的LV舒张末压(58±4 mmHg)高于心脏停搏液组心脏(41±4 mmHg;与第1组相比,P <.05);在预处理组心脏和预处理加心脏停搏液组心脏中观察到最佳保护效果(分别为24±1和26±2 mmHg;与第1组和第2组相比,P <.05)。
当心脏停搏液输送受损时,缺血预处理能更好地保护心肌(缺血后LVDP)。在相同条件下,与单独使用心脏停搏液相比,心脏停搏液加预处理的联合应用提供了更好的保护。这些结果可能具有临床意义,因为大多数接受缺血性心脏病手术的患者患有严重冠状动脉病变,这可能会妨碍心脏停搏液的充分输送。